Abstract
A chronic relapsing arthritis develops after a single subcutaneous injection of small amounts of pristane; the pristane induced arthritis (PIA) model in the rat. PIA is characterized by a sudden onset of disease 2 wk after induction. The main pathological features of PIA include edema accompanied by an acute phase response, infiltration into the joint of mononuclear and polymorphonuclear cells, pannus formation, and erosion of cartilage and bone. PIA is a disease that is largely T-cell dependent that can be adoptively transferred by activated CD4+ T-cells. PIA in rats is followed clinically by macroscopic scoring and is characterized by an early acute phase of severe inflammation after onset that eventually gradually disappears to be followed by less severe relapsing phases of new inflamed joints and increasing cartilage erosion and joint deformity. PIA can be diagnosed by biochemical analyzes in plasma that reflects systemic inflammation (α1-acid glycoprotein (AGP) and IL-6) and cartilage erosion (COMP).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pearson, C. M. (1956) Development of arthritis, periarthritis and perioscitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91, 91–101.
Holmdahl, R., Lorentzen, J. C., Lu, S., Olofsson, P., Wester, L., Holmberg, J., and Pettersson, U. (2001) Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 184, 184–202.
Kleinau, S., Erlandsson, H., Holmdahl, R., and Klareskog, L. (1991) Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J. Autoimmun. 4, 871–880.
Kleinau, S., and Klareskog, L. (1993) Oil-induced arthritis in DA rats passive transfer by T cells but not with serum. J Autoimmun 6, 449–458.
Holmdahl, R., Goldschmidt, T. J., Kleinau, S., Kvick, C., and Jonsson, R. (1992) Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 76, 197–202.
Garrett, L. R., Chung, J. G., Byers, P. E., and Cuchens, M. A. (1989) Dietary effects of pristane on rat lymphoid tissues. Agents Actions 28, 272–278.
Arnett, F. C., Edworthy, S. M., Bloch, D. A., et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315–324.
Vingsbo, C., Sahlstrand, P., Brun, J. G., Jonsson, R., Saxne, T., and Holmdahl, R. (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149, 1675–1683.
Olofsson, P., Nordquist, N., Vingsbo-Lundberg, C., et al. (2002) Genetic links between the acute-phase response and arthritis development in rats. Arthritis Rheum. 46, 259–268.
Svelander, L., Holm, B. C., Buchtt, A., and Lorentzen, J. C. (2001) Responses of the rat immune system to arthritogenic adjuvant oil. Scand. J. Immunol. 54, 599–605.
Olofsson, P., Holmberg, J., Pettersson, U., and Holmdahl, R. (2003) Identification and isolation of dominant susceptibility loci for pristane-induced arthritis. J. Immunol. 171, 407–416.
Vingsbo-Lundberg, C., Saxne, T., Olsson, H., and Holmdahl, R. (1998) Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum. 41, 544–550.
Wester, L., Olofsson, P., Ibrahim, S. M., and Holmdahl, R. (2003) Chronicity of pristane-induced arthritis in rats is controlled by genes on chromosome 14. J. Autoimmun. 21, 305–313.
Kleinau, S., Dencker, L., and Klareskog, L. (1995) Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane. Int. J. Immunopharmacol. 17, 393–401
Holm, B. C., Svelander, L., Bucht, A., and Lorentzen, J. C. (2002) The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes. Clin. Exp. Immunol. 127, 430–435.
Rodriguez-Palmero, M., Pelegri, C., Ferri, M. J., Castell, M., Franch, A., and Castellote, C. (1999) Alterations of lymphocyte populations in lymph nodes but not in spleen during the latency period of adjuvant arthritis. Inflammation 23, 153–165
Yoshino, S., Schlipkoter, E., Kinne, R., Hunig, T., and Emmrich, F. (1990) Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur. J. Immunol. 20, 2805–2808
Larsson, P., Holmdahl, R., Dencker, L., and Klareskog, L. (1985) In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 56, 383–391
Pelegri, C., Paz Morante, M., Castellote, C., Castell, M., and Franch, A. (1995) Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25. Cell Immunol. 165, 177–182
Pelegri, C., Morante, M. P., Castellote, C., Franch, A., and Castell, M. (1996) Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis. Clin. Exp. Immunol. 103, 273–278
Santos, L. L., Morand, E. F., Hutchinson, P., Boyce, N. W., and Holdsworth, S. R. (1997) Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin. Exp. Immunol. 107, 248–253.
Stuart, J. M., Cremer, M. A., Townes, A. S., and Kang, A. H. (1982) Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med. 155, 1–16
Taurog, J. D., Sandberg, G. P., and Mahowald, M. L. (1983) The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient. Cell Immunol. 75, 271–282.
Ulmansky, R., and Naparstek, Y. (1995) Immunoglobulins from rats that are resistant to adjuvant arthritis suppress the disease in arthritis-susceptible rats. Eur. J. Immunol. 25, 952–957.
Taurog, J. D., Sandberg, G. P., and Mahowald, M. L. (1983) The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol. 80, 198–204.
Svelander, L., Mussener, A., Erlandsson-Harris, H., and Kleinau, S. (1997) Polyclonal Th1 cells transfer oil-induced arthritis. Immunology 91, 260–265.
Carlson, B. C., Jansson, A. M., Larsson, A., Bucht, A., and Lorentzen, J. C. (2000) The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am. J. Pathol. 156, 2057–2065.
Heidrich, H. J. (1990) Genetic monitoring of inbred strains of rats, Gustav Fischer Verlag, Stuttgart, New York.
Carlsen, S., Hansson, A. S., Olsson, H., Heinegard, D., and Holmdahl, R. (1998) Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin. Exp. Immunol. 114(3), 477–484.
Aarden, L. A., De Groot, E. R., Schaap, O. L., and Lansdorp, P. M. (1987) Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17, 1411–1416.
Holmdahl, R., Carlsén, S., Mikulowska, A., et al. (1998) In: Human Genome Methods, Adolph, K. W., ed.,, New York:, CRC Press LLC, New York, USA. pp. 215–238.
McConahey, P. J., and Dixon, F. J. (1980) Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 70, 210–213.
Holmberg, J., Tuncel, J., Yamada, H., Lu, S,. Olofsson, P., and Holmdahl, R. (2006) Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J. Immunol. 176(2), 1172–1179.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Olofsson, P., Holmdahl, R. (2007). Pristane-Induced Arthritis in the Rat. In: Cope, A.P. (eds) Arthritis Research. Methods in Molecular Medicine, vol 136. Humana Press. https://doi.org/10.1007/978-1-59745-402-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-59745-402-5_19
Publisher Name: Humana Press
Print ISBN: 978-1-58829-918-5
Online ISBN: 978-1-59745-402-5
eBook Packages: Springer Protocols